Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on AMIX as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AMIX just turned positive on June 26, 2025. Looking at past instances where AMIX's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMIX advanced for three days, in of 53 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for AMIX moved out of overbought territory on June 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
AMIX moved below its 50-day moving average on June 30, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AMIX broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMIX entered a downward trend on June 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.348). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (42.660).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry MedicalSpecialties
A.I.dvisor tells us that AMIX and SERA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMIX and SERA's prices will move in lockstep.
Ticker / NAME | Correlation To AMIX | 1D Price Change % | ||
---|---|---|---|---|
AMIX | 100% | N/A | ||
SERA - AMIX | 27% Poorly correlated | +3.76% | ||
MODD - AMIX | 20% Poorly correlated | +3.73% | ||
ALUR - AMIX | 5% Poorly correlated | +4.55% | ||
NXL - AMIX | 4% Poorly correlated | +0.61% | ||
TLSI - AMIX | 4% Poorly correlated | -0.20% | ||
More |
Ticker / NAME | Correlation To AMIX | 1D Price Change % |
---|---|---|
AMIX | 100% | N/A |
Medical Specialties category (422 stocks) | 7% Poorly correlated | -1.38% |
Medical Specialties category (392 stocks) | 7% Poorly correlated | -1.41% |